You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.

DUBLIN--(BUSINESS WIRE)--The "HER2 Antibodies - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global HER2 Antibodies Market to Reach $22.3 Billion by 2027 Amid the COVID-19 crisis, the global market for HER2 Antibodies estimated at US$12.8 Billion in the year 2020, is projected to reach a revised size of US$22.3 Billion by 2027, growing at a CAGR of 8.3% over the analysis period 2020-2027. Trastuzumab, one of the segments analyzed in the report, is projected to record a 8.7% CAGR and reach US$14.6 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Lapatinib segment is readjusted to a revised 7.9% CAGR for the next 7-year period. The U.S. Market is Estimated at $3.8 Billion, While China is Forecast to Grow at 7% CAGR The HER2 Antibodies market in the U.S. is estimated at US$3.8 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$3.7 Billion by the year 2027 trailing a CAGR of 7% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.9% and 7.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.2% CAGR. Ado-trastuzumab emtansine Segment to Record 7.3% CAGR In the global Ado-trastuzumab emtansine segment, USA, Canada, Japan, China and Europe will drive the 7.3% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$775.3 Million in the year 2020 will reach a projected size of US$1.3 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$2.7 Billion by the year 2027. Key Topics Covered: I. METHODOLOGY II. EXECUTIVE SUMMARY 1. MARKET OVERVIEW 2. FOCUS ON SELECT PLAYERS (Total 47 Featured): 3. MARKET TRENDS & DRIVERS 4. GLOBAL MARKET PERSPECTIVE III. MARKET ANALYSIS IV. COMPETITION For more information about this report visit https://www.researchandmarkets.com/r/7qiysd

Answer: Global HER2 Antibodies Market Report 2021: Market to Reach $22.3 Billion - Trastuzumab to Account for $14.6 Billion of the Total Market - ResearchAndMarkets.com